Pesquisando:Doing more in the US
Ver todas as funcionalidades
Arthur - Oncology scientist
Arthur

GSK Scientist
Upper Providence, PA

Can you imagine personalized cancer treatments?

Because no two cancers are the same and no two people are the same, our Oncology scientists are working on medicines that harness a patient’s own immune system to destroy tumors.

Doing more in the US

Call for IME propososals (SLE) overview image. Model name - Michelle Thomas, UK

Across the US, we employ more than 15,000 people - from our Vaccines R&D headquarters in Maryland, to our R&D Hub in Pennsylvania, and from one of our nearly 10 manufacturing sites across America, our employees and our values are at the heart of everything we do. This work starts one person, one community, and one story at a time. 

You may also like

Cancer cells

Cancer gets a sting with new discovery

A paper authored by 44 of our scientists was published in the scientific journal Nature, revealing a potential new class of immunotherapy drugs to treat some cancers.
Dart hitting dartboard

On target for a new era of drug discovery?

Almost half a century ago, the world entered an apparent golden era of drug discovery. Driven by a rapidly advancing understanding of biological processes in the body and medicinal chemistry, a generation of game-changing new medicines emerged.
Voltar ao topo